DexCom, Inc. (FRA:DC4)

DexCom Statistics

Total Valuation

DexCom has a market cap or net worth of EUR 24.01 billion. The enterprise value is 23.71 billion.

Market Cap	24.01B
Enterprise Value	23.71B

Important Dates

The last earnings date was Thursday, October 23, 2025.

Earnings Date	Oct 23, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	392.16M
Shares Outstanding	n/a
Shares Change (YoY)	-2.97%
Shares Change (QoQ)	+0.17%
Owned by Insiders (%)	0.31%
Owned by Institutions (%)	93.94%
Float	389.52M

Valuation Ratios

The trailing PE ratio is 49.33 and the forward PE ratio is 29.77.

PE Ratio	49.33
Forward PE	29.77
PS Ratio	6.56
PB Ratio	10.96
P/TBV Ratio	11.45
P/FCF Ratio	49.39
P/OCF Ratio	28.54
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 28.68, with an EV/FCF ratio of 48.77.

EV / Earnings	48.71
EV / Sales	6.40
EV / EBITDA	28.68
EV / EBIT	40.04
EV / FCF	48.77

Financial Position

The company has a current ratio of 1.52, with a Debt / Equity ratio of 1.00.

Current Ratio	1.52
Quick Ratio	1.30
Debt / Equity	1.00
Debt / EBITDA	2.69
Debt / FCF	4.52
Interest Coverage	36.17

Financial Efficiency

Return on equity (ROE) is 22.83% and return on invested capital (ROIC) is 8.44%.

Return on Equity (ROE)	22.83%
Return on Assets (ROA)	6.08%
Return on Invested Capital (ROIC)	8.44%
Return on Capital Employed (ROCE)	17.10%
Revenue Per Employee	357,281
Profits Per Employee	47,476
Employee Count	10,300
Asset Turnover	0.61
Inventory Turnover	3.05

Taxes

In the past 12 months, DexCom has paid 181.03 million in taxes.

Income Tax	181.03M
Effective Tax Rate	27.11%

Stock Price Statistics

The stock price has decreased by -9.69% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-9.69%
50-Day Moving Average	62.20
200-Day Moving Average	70.16
Relative Strength Index (RSI)	56.90
Average Volume (20 Days)	470

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.67

Income Statement

In the last 12 months, DexCom had revenue of EUR 3.66 billion and earned 486.63 million in profits. Earnings per share was 1.22.

Revenue	3.66B
Gross Profit	2.15B
Operating Income	585.15M
Pretax Income	667.66M
Net Income	486.63M
EBITDA	786.19M
EBIT	585.15M
Earnings Per Share (EPS)	1.22

Balance Sheet

The company has 2.49 billion in cash and 2.20 billion in debt, giving a net cash position of 298.03 million.

Cash & Cash Equivalents	2.49B
Total Debt	2.20B
Net Cash	298.03M
Net Cash Per Share	n/a
Equity (Book Value)	2.19B
Book Value Per Share	5.59
Working Capital	1.47B

Cash Flow

In the last 12 months, operating cash flow was 841.03 million and capital expenditures -354.99 million, giving a free cash flow of 486.04 million.

Operating Cash Flow	841.03M
Capital Expenditures	-354.99M
Free Cash Flow	486.04M
FCF Per Share	n/a

Margins

Gross margin is 58.77%, with operating and profit margins of 15.98% and 13.29%.

Gross Margin	58.77%
Operating Margin	15.98%
Pretax Margin	18.23%
Profit Margin	13.29%
EBITDA Margin	21.47%
EBIT Margin	15.98%
FCF Margin	13.27%

Dividends & Yields

DexCom does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	2.97%
Shareholder Yield	2.97%
Earnings Yield	2.03%
FCF Yield	2.02%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on June 13, 2022. It was a forward split with a ratio of 4.

Last Split Date	Jun 13, 2022
Split Type	Forward
Split Ratio	4

Scores

DexCom has an Altman Z-Score of 5.47 and a Piotroski F-Score of 6.

Altman Z-Score	5.47
Piotroski F-Score	6